MHLW Approved GSK’s Lamictal And Pfizer’s Genotropin Among Other Drugs
This article was originally published in PharmAsia News
Executive Summary
The first division on drugs of Ministry of Health, Labor and Welfare's Pharmaceutical Affairs and Food Sanitation Council approved July 25 GlaxoSmithKline's antiepileptic drug Lamictal (lamotrigine) to treat partial seizures in pediatric and adult patients with Lennox-Gastaut syndrome, Pfizer's human growth hormone Genotropin (somatropin), Novartis' Neoral (cyclosporine) to treat atopic dermatitis, Santan Pharmaceutical's tafluprost to treat galucoma and ocular hypertension, Aska Pharmaceutical's Menoaid Combipatch to treat menopausal symptoms and Schering-Plough's Bepricor (bepridil) to treat atrial fibrillation.(Click here for more - Japanese language) "First Section Of PAFSC Approves Epilepsy Drug Lamictal Among Other Drugs" - Yakuji News (7/29/08)